NCT02040337View on ClinicalTrials.gov

Sequencing T-cells in Type I Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 1, 2017

Study Completion Date

December 13, 2017

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Trial Locations (1)

78701

University of Texas Physicians at Trinity, Austin

All Listed Sponsors
collaborator

Cancer Prevention Research Institute of Texas

OTHER

lead

Seton Healthcare Family

OTHER

NCT02040337 - Sequencing T-cells in Type I Diabetes Mellitus | Biotech Hunter | Biotech Hunter